Janssen, Johnson & Johnson's pharmaceutical arm, launched a nine-month digital health startup accelerator focusing on predictive diagnostic models and treatment management devices.
The initiative, which will focus primarily on startups in the Middle East, Africa and Europe, will provide startups with nine months of support and mentorship from Janssen and iPEPS, the Paris-based Brain and Spine Institute's brain disease-focused innovation accelerator.
Startups can apply to the accelerator until Sept. 27 by explaining their plans to improve medical treatment with predictive diagnostics and/or precision treatment management tools. Pitches will be accepted until Sept. 27.